Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/07/21
Black Diamond Therapeutics to Present Phase 1 BDTX-189 Data in Advanced Solid Tumors at American Society of Clinical OncologyGlobeNewsWire • 04/28/21
Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual MeetingGlobeNewsWire • 04/10/21
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/25/21
Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual MeetingGlobeNewsWire • 03/10/21
Black Diamond Therapeutics Announces Pre-Clinical Data Presentations on New Programs Targeting BRAF and FGFR at ESMO TAT Virtual Congress 2021GlobeNewsWire • 03/02/21
Black Diamond Therapeutics Announces Appointment of Oncology Clinical Development Veteran Dr. Kapil Dhingra to Board of DirectorsGlobeNewsWire • 01/20/21
Black Diamond Therapeutics to Present at the J.P. Morgan 39th Annual Healthcare ConferenceGlobeNewsWire • 01/05/21
Black Diamond Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/24/20
Black Diamond Therapeutics Provides Update on GBM Program and Presents Pre-Clinical Data at the 2020 SNO Annual MeetingGlobeNewsWire • 11/20/20
Black Diamond Therapeutics to Present at the Jefferies 2020 Virtual London Healthcare ConferenceGlobeNewsWire • 11/11/20
Black Diamond Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/10/20
Black Diamond Therapeutics Presents Pre-Clinical Data on Lead Product Candidate BDTX-189 at the 32nd EORTC-NCI-AACR Virtual SymposiumGlobeNewsWire • 10/26/20
Black Diamond Therapeutics to Present Pre-Clinical Data on Lead Product Candidate BDTX-189 at the 32nd EORTC-NCI-AACR Virtual SymposiumGlobeNewsWire • 10/12/20
Black Diamond Therapeutics Announces the Appointment of Biopharmaceutical Veteran Robert A. Ingram as Chairman of the BoardGlobeNewsWire • 09/29/20
Black Diamond Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare ConferenceGlobeNewsWire • 09/10/20
Black Diamond Therapeutics Announces the Appointment of Rachel Humphrey, M.D., as Chief Medical OfficerGlobeNewsWire • 09/08/20
Black Diamond Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/11/20
Is a Surprise Coming for Black Diamond Therapeutics (BDTX) This Earnings Season?Zacks Investment Research • 08/10/20
Black Diamond Therapeutics Announces the Appointment of Fang Ni as Chief Business OfficerGlobeNewsWire • 08/04/20
Black Diamond Therapeutics Granted Fast Track Designation by the FDA for BDTX-189 for the Treatment of Adult Patients with a Solid Tumor Harboring an Allosteric HER2 Mutation or an EGFR or HER2 Exon 20 Insertion MutationGlobeNewsWire • 07/28/20
Black Diamond Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare ConferenceGlobeNewsWire • 06/16/20
How Black Diamond Therapeutics (BDTX) Stock Stands Out in a Strong IndustryZacks Investment Research • 05/14/20